“Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya Smale

ChrisCashmanPresImage
Chris Cashman of Marinus Pharmaceuticals Inc.   joined us for World Orphan Drug Conference USA 2015 to present about ‘ Leading Innovation in Treatment of Epilepsy and Neuropsychiatric Disorders’ 
Download the presentation to learn about:

  • Ganaxalone: First-In-Class Therapeutic for Epilepsy and Neuropsychiatric Disorders
  • Diversified Clinical Stage Opportunities
  • Behaviors in Fragile X Syndrome
  • Intravenous Formulation

…and much more! 

Get your copy here

 To find out more about Marinus Pharmaceuticals and Gaxalone , attend  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.